A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) | MicrobiomeTrials
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2020-09-09Est. Completion: 2022-07-29
Enrollment target: 150 participants
Locations
Site #143, Bentonville, Arkansas, United States
Site # 249, Little Rock, Arkansas, United States
Site #153, Culver City, California, United States
Site #239, Garden Grove, California, United States
Site # 243, Glendale, California, United States
Site #134, Lemon Grove, California, United States
Site #163, Oceanside, California, United States
Site # 247, Pico Rivera, California, United States
Site # 229, Rancho Cucamonga, California, United States
Site # 237, San Diego, California, United States
Site # 150, Stanford, California, United States
Site #202, Miami, Florida, United States
Site #144, Miami Lakes, Florida, United States
Site #144, North Miami, Florida, United States
Site #241, Okeechobee, Florida, United States
Site # 240, Chicago, Illinois, United States
Site #140, Chicago, Illinois, United States
Site #140, Lincolnwood, Illinois, United States
Site #225, Flowood, Mississippi, United States
Other microbiome trials you might be interested in